September 10, 2025

Recent advances in biomarkers for diabetes mellitus and tuberculosis comorbidity: a comprehensive review.

View Full Paper

Ask AI

Bookmark

Early detection of diabetes mellitus can significantly improve tuberculosis outcomes, supporting the need for better biomarker identification.
The review discusses the importance of microbial and metabolic markers in diagnosing diabetes-tuberculosis comorbidity effectively.
Identified immunological biomarkers provide crucial insights into disease severity in individuals with diabetes and tuberculosis.
Clinical biomarkers demonstrate high diagnostic accuracy, with CA-125 showing sensitivity of 88.14% and specificity of 95.83%.

Discussion

No takes yet. Share an insight, caveat, or question.

Comprehensive review highlights recent biomarker advances for diabetes and tuberculosis comorbidity, suggesting integration for better management.

Fang et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Comprehensive review highlights recent biomarker advances for diabetes and tuberculosis comorbidity, suggesting integration for better management.